May 13, 2026
Melanotan 1 (MT-1) Research Guide
Melanotan 1 is the more selective alpha-MSH analogue, focused primarily on MC1R activation in melanocytes. Marketed as afamelanotide, it received FDA approval in 2019…
Read Protocol →Research Library
In-depth research summaries, reconstitution guides, and compound comparisons for serious researchers.
May 13, 2026
Melanotan 1 is the more selective alpha-MSH analogue, focused primarily on MC1R activation in melanocytes. Marketed as afamelanotide, it received FDA approval in 2019…
Read Protocol →
May 13, 2026
Melanotan 2 is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) developed at the University of Arizona in the 1980s. It activates the melanocortin…
Read Protocol →
May 13, 2026
The CJC-1295 plus Ipamorelin blend pairs two complementary growth-hormone-axis peptides into a single research preparation. CJC-1295 (the No DAC variant) acts on the GHRH…
Read Protocol →
May 13, 2026
The BPC-157 plus TB-500 blend pairs the two most-studied tissue-repair peptides into a single research preparation. The combination has appeared in dozens of independent…
Read Protocol →
May 13, 2026
KPV is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), studied for its anti-inflammatory effects in models of inflammatory bowel disease, skin inflammation, and…
Read Protocol →
May 13, 2026
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene, discovered in 2015 as one of the first identified mitochondrial-derived peptides with…
Read Protocol →
May 13, 2026
Semax is a synthetic heptapeptide originally developed in the Soviet Union as a stable analogue of the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10).…
Read Protocol →
May 13, 2026
GHK-Cu is a naturally occurring tripeptide-copper complex first isolated from human plasma in 1973. Across five decades of research it has emerged as one…
Read Protocol →
May 13, 2026
NAD+ (nicotinamide adenine dinucleotide) is one of the most important coenzymes in mammalian biology, central to energy metabolism, DNA repair, and longevity-related signaling pathways.…
Read Protocol →
May 13, 2026
Tesamorelin is a stabilized analogue of growth-hormone-releasing hormone (GHRH) developed by Theratechnologies. Originally approved by the FDA in 2010 for HIV-associated lipodystrophy, it remains…
Read Protocol →Aeternum Labs
This site sells peptides and compounds for in vitro laboratory research purposes only. They are not intended for human or animal consumption, and are not approved by the FDA.